Arcus Biosciences Capital Raise of $288M
Arcus Biosciences completed a public offering of 16,428,572 shares of common stock, including the full exercise of the underwriters' option to purchase additional shares. The offering was priced at $17.50 per share, resulting in net proceeds of approximately $269.7 million after fees and expenses.
- Value
- $288M
- Counterparty
- Jefferies LLC, Leerink Partners LLC and TD Securities (USA) LLC